Aurora Exo Series Ortho Targeted Biotherapy in Regenerative Orthopedics: Lyophilized, Osteogenic and Chondrogenic Differentiated Cell-Derived Exosomes
Open the catalog to page 1Aurora Exo Series Ortho® Advantages Content Engineering: Targeted Differentiation Clinical and Surgical Application Scenarios
Open the catalog to page 2In musculoskeletal system regeneration, extracellular vesicles and especially exosomes (30-150 nm) are at the center of the "cell-free therapy" paradigm. It has been shown that the effects of mesenchymal stem cells on bone and cartilage repair are largely mediated through paracrine secretions, especially exosomes[1]. These nanovesicles manage the repair programs of target cells with the specific microRNAs and growth factors they carry.
Open the catalog to page 304 Aurora Exo Series Ortho® Advantages Aurora Exo Series Ortho® offers significant advantages in clinical use with its lyophilized form: Critical Advantages of Lyophilization optimized critical drying process preserves therapeutic efficacy by maintaining vesicle integrity and the activity of biological content (e.g., osteogenic miRNA-29ar chondrogenic miRNA-140). 1Superior Thermal Stability Eliminates the requirement for -80°C deep freezing. With a long shelf life at +4°C, it greatly facilitates product logistics and storage. Precise and Standardized Dose Each 5 ml vial contains exactly 5 billion...
Open the catalog to page 405 A Special Approach: Aurora Exo Series Ortho® Compared to general MSC exosomes, directing the source cell to specific tissues relies on enriching the exosome cargo. This is a "content engineering" strategy. Exo Ortho product for orthopedic applications by converting MSCs obtained from cord tissue into osteogenic or chondrogenic precursors. Osteogenic Exosomes: These exosomes naturally carry enriched bone morphogenetic protein (BMP) signaling pathway components, proteins such as osteocalcin, osteopontin, and microRNAs that regulate bone formation such as miR-29a, miR-148a . Chondrogenic Exosomes:...
Open the catalog to page 506 Clinical and Surgical Application Scenarios Osteoarthritis: As an intra-articular injection, for symptomatic and structural modifying treatment purposes. Critical Bone Defects: Local application by mixing with bone graft or synthetic scaffolds. Osteochondral Lesions: Synchronizing both cartilage and subchondral bone repair. Spinal Fusion and Arthrodesis: By adding to the graft material to optimize fusion success and duration. Meniscus and Labrum Injuries: Minimally invasive injections to support tissue repair.
Open the catalog to page 607 References [1] Robbins, P. D., & Morelli, A. E. (2014). Regulation of immune responses by extracellular vesicles. Nature Reviews Immunology. DOI: 10.1038/nri3622 [2] Charoenviriyakul, C., Takahashi, Y., et al. (2018). Preservation of exosomes in an ambient temperature for a long term storage. Scientific Reports. DOI: 10.1038/s41598-018-19985-9 [3] Bosch, S., de Beaurepaire, L., et al. (2016). Trehalose prevents aggregation of exosomes during cryopreservation. Biochemical and Biophysical Research Communications. DOI: 10.1016/j.bbrc.2016.05.146 [4] Qin, Y., Wang, L., et al. (2016). Bone marrow...
Open the catalog to page 71 Page
1 Page
63 Pages
6 Pages
1 Page
1 Page
1 Page
1 Page
1 Page
1 Page
1 Page
1 Page
1 Page
1 Page
1 Page
1 Page
1 Page
1 Page
1 Page
1 Page
9 Pages
9 Pages